The recent COVID-19 pandemic has profoundly impacted global malaria elimination
programs, resulting in a sharp increase in malaria morbidity and mortality. To reduce this …

Introduction: For the COVID-19 (SARS-CoV-2) response, COVID-19 antigen (Ag), and
antibody (Ab) rapid diagnostic tests (RDTs) are expected to complement central molecular …

Background Malaria remains a significant public health challenge in Sub-Saharan Africa
(SSA), particularly affecting under-five (UN5) children. Despite global efforts to control the …

Abstract Background Rapid diagnostic tests (RDTs) play a significant role in expanding case
management in peripheral healthcare systems. Histidine-rich protein-2 (HRP2) antigen …

Malaria is a major cause of illness and death worldwide. Rapid diagnostic tests are the most
widely used tool for detecting malaria infection, however, they only provide binary results …

The majority of Plasmodium falciparum malaria diagnoses in Africa are made using rapid
diagnostic tests (RDTs) that detect histidine-rich protein 2. Increasing reports of false …

Introduction Malaria continues to be a major global health problem, with over 228 million
cases and 405,000 deaths estimated to occur annually. Rapid and accurate diagnosis of …

Background Adoption of molecular techniques to detect Plasmodium falciparum infection
has revealed many previously undetected (by microscopy) yet transmissible low-density …

Malaria is a deadly disease caused by protozoan pathogens of the Plasmodium parasite.
Transmission to humans occurs through the bite of an infected female Anopheles mosquito …

The identification and characterization of proteins produced during human infection with
Plasmodium spp. have guided the malaria community in research, diagnosis, epidemiology …